Heilongjiang ZBD Pharmaceutical Co., Ltd. (603567.SS)

CNY 12.25

(4.08%)

Market Cap (In CNY)

11.5 Billion

Revenue (In CNY)

3.13 Billion

Net Income (In CNY)

472.74 Million

Avg. Volume

2.77 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
8.89-13.63
PE
-
EPS
-
Beta Value
0.345
ISIN
CNE100002219
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Lei Wang
Employee Count
-
Website
https://www.zbdzy.com
Ipo Date
2015-04-24
Details
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.